- Wildflower Brands is an integrated health and wellness company
- WLDFF offers a complete lineup of full-spectrum CBD-infused products
- The company recently signed a Polish distribution agreement
Wildflower Brands Inc. (CSE: SUN) (OTCQB: WLDFF) develops and designs brands that focus on plant-based health and wellness products. Wildflower has an innovative and holistic business model that incorporates research and development (R&D), manufacturing, distribution, marketing and retail. The company’s brands include Wildflower Wellness and King Extracts. Wildflower Brands operates out of Washington State and California and sells across the United States.
Wildflower works in regulated cannabis markets in the United States in accordance with respective regulations, marketing its THC and CBD+ products. The company focuses on creating unique brands that work synergistically toward moving the company ahead to becoming an international wellness brand leader.
For example, Wildflower Wellness offers a comprehensive lineup of full-spectrum CBD-infused products made in the United States. The company’s California-based King Extracts centers on cannabis technology and delivery systems.
Wildflower Brands recently signed a distribution agreement with wholesaler Two Towers. Based in Poland, Two Towers is one of that country’s major wholesale prescription medical and over-the-counter wellness distribution companies (http://ibn.fm/pVulU). Two Towers distributes products from a wide-ranging list of worldwide leaders in pharmaceutical and consumer packaged goods. This distribution agreement advances Wildflower’s strategy for global growth and opens up expansion opportunities in the European Union.
Furthermore, Wildflower Brands is expanding its cannabis retail presence with City Cannabis Corp., a premier licensed cannabis retailer in British Columbia. Wildflower entered into a nonbinding letter of intent (LOI) last month to acquire City Cannabis in exchange for common shares of Wildflower Brands. City Cannabis holds two of the six City of Vancouver licenses to sell cannabis. It is the first company with multiple licenses in British Columbia (http://ibn.fm/07UGk).
This month, Wildflower Brands announced the signing of an agreement with Highmark Interactive to study the cognitive and functional neurological effects of cannabinoids via clinical research. The two companies will take advantage of Highmark’s industry-leading mobile software EQ – Active Brain Tracking. The aim of the research sponsorship is to create meaningful data and results, which could unlock new paths of understanding regarding the cognitive and functional neurological effects of cannabinoids (http://ibn.fm/swejm). A medical technology company, Highmark Interactive concentrates on assessing neurological functional performance and how it is affected after mild traumatic brain injuries and other neurological diseases.
“Wildflower continues to receive a flood of testimonials from consumers on our products that support wellness and health needs through plant-based solutions,” Wildflower Brands CEO William MacLean stated in a news release. “We always strive for improvements in our products and our understanding of those products, and this research commits us to that goal as an investment in the growth of our industry. Highmark Interactive brings the right skills and relationships to the table, and we are excited to see the results of our work together.”
Wildflower Brands is committed to creating and providing options for people seeking holistic wellness and health. For its customers, the company continues to study and develop better and improved ingredients and formulations. For investors, Wildflower offers the potential for portfolio growth with its precise global expansion strategy and dedication to superior products and a first-class consumer retail experience.
For more information, visit the company’s website at www.WildflowerBrands.co